Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Hofmann

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
JAMA|September 1, 2025
Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART TrialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart FailureStefan James, David Erlinge, Robert F Storey, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 8, 2026
Prognostic Value of Impaired Spirometry in Patients with Myocardial Infarction: A Longitudinal Study of Two European CohortsJosefin Sundh, William A E Parker, Jonas Oldgren, et al.
BMJ Open|May 9, 2025
Prevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional studyWilliam A E Parker, Josefin Sundh, Jonas Oldgren, et al.
The New England Journal of Medicine|November 10, 2025
Beta-Blockers after Myocardial Infarction with Normal Ejection FractionAnna Meta Dyrvig Kristensen, Xavier Rossello, Dan Atar, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
JAMA|September 1, 2025
Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART TrialRobin Hofmann, Stefan James, Martin O Sundqvist, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart FailureStefan James, David Erlinge, Robert F Storey, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 8, 2026
Prognostic Value of Impaired Spirometry in Patients with Myocardial Infarction: A Longitudinal Study of Two European CohortsJosefin Sundh, William A E Parker, Jonas Oldgren, et al.
BMJ Open|May 9, 2025
Prevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional studyWilliam A E Parker, Josefin Sundh, Jonas Oldgren, et al.
The New England Journal of Medicine|November 10, 2025
Beta-Blockers after Myocardial Infarction with Normal Ejection FractionAnna Meta Dyrvig Kristensen, Xavier Rossello, Dan Atar, et al.
Pageof 8